Review Med Lp - Dallas, Texas 75231

Review Med Lp is categorized under Business Management Consultants in Dallas, TX .

Business Name: Review Med Lp
Contact Person: Leo prendergast
Address: 10300 N Central Expressway, Dallas, Texas 75231
Phone Number: (469) 232-5419
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founding Year: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Management Consultants
Share This Business:
Related Businesses: Oepan - Dallas, TX 75231
Richard Jaffe & CO Inc - Dallas, TX 75231
Page-Wheatcroft - Dallas, TX 75231
Princeton Review - Dallas, TX 75231
Jfa Consulting Inc - Dallas, TX 75231
Fregonese Associates - Dallas, TX 75231
Rachal And Associates Hal Rachal - Dallas, TX 75231
Morgenthau And Associates Inc - Dallas, TX 75231
Charles Taylor Aviation - Dallas, TX 75231
World Business Federation - Dallas, TX 75231
Hampton & Assoc Inc - Dallas, TX 75231
Diversity Trends - Dallas, TX 75231
Johnson Financial Group - Dallas, TX 75231
Charles Taylor Consulting - Dallas, TX 75231
Jbc Business Service - Dallas, TX 75231
Deno Barroga & Assoc - Dallas, TX 75231
Rylander Associates - Dallas, TX 75231
Bikyco One Inc - Dallas, TX 75231
Ni Wang & Associates Pllc - Dallas, TX 75231
Dais Associates - Dallas, TX 75231

The company Review Med Lp provides B2B services in the form of Business Management Consultants from its single location in Texas. 1 to 4 employees work for Review Med Lp, and the business now earns $10.000.000 to $19.9999.999 per annum.

Review Med Lp was launched in 1997 and is classified under SIC code and category , and NAICS number and grouping . To contact Review Med Lp, please call Leo prendergast with the phone number (469) 232-5419 or visit its single location at 10300 N Central Expressway in Dallas, Texas 75231.

The location of the single location can also be found using the coordinates 32.88749,-96.76951. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.